StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Pfizer (PFE), GlaxoSmithKline Company ViiV Healthcare Highlights Phase III Data at AIDS 2018
July 24, 2018 5:49 AM
ViiV Healthcare, a global specialist HIV company established in November 2009 by GlaxoSmithKline (GSK) and Pfizer (NYSE: PFE), today presented ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
FDA
Management Comments
Next Articles
Pfizer (PFE), GlaxoSmithKline Company ViiV Healthcare Announces SWORD 100-Week Data for Juluca (dolutegravir/rilpivirine) at AIDS 2018
July 24, 2018 5:54 AM
ViiV Healthcare Presents Phase III Data at AIDS 2018 from Landmark GEMINI Studies Showing Two-Drug Regimen of Dolutegravir and Lamivudine Has Similar Efficacy to a Three-Drug Regimen in Treatment Naï
July 24, 2018 5:35 AM
Pre-Open Movers 07/23: (DDE) (LPNT) (HAS) Higher; (GST) (PETS) (ITW) Lower (more...)
July 23, 2018 9:31 AM
Leap Therapeutics (LPTX) Reports Collaboration with Merck KGaA, Darmstadt, Germany, and Pfizer (PFE) to Evaluate Combination of TRX518, Avelumab, and Chemotherapy
July 23, 2018 7:33 AM
Leap Therapeutics (LPTX) Announces Pact with Merck KGaA and Pfizer (PFE) to Evaluate Combination of TRX518, Avelumab, and Chemotherapy in Advanced Solid Tumors
July 23, 2018 7:31 AM
Pfizer (PFE) Announces FDA Approves for its Neupogen Biosimilar NIVESTYM
July 20, 2018 4:26 PM
Pfizer's (PFE) Biosimilar to Amgen's (AMGN) Neupogen Approved by FDA - Bloomberg
July 20, 2018 3:10 PM